 William Woodward
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Stress | 4 | 2025 | 25 | 2.130 |
Why?
| | Sympathetic Nervous System | 13 | 2024 | 182 | 1.710 |
Why?
| | Norepinephrine | 14 | 2024 | 204 | 1.600 |
Why?
| | Myocardial Infarction | 8 | 2025 | 1046 | 1.080 |
Why?
| | Coronary Artery Disease | 5 | 2025 | 698 | 1.010 |
Why?
| | Methoxyhydroxyphenylglycol | 3 | 2024 | 13 | 0.800 |
Why?
| | Schools | 2 | 2019 | 461 | 0.590 |
Why?
| | Electrochemical Techniques | 1 | 2018 | 54 | 0.560 |
Why?
| | Psychology | 2 | 2010 | 85 | 0.530 |
Why?
| | Students | 2 | 2019 | 622 | 0.510 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2018 | 597 | 0.510 |
Why?
| | Action Potentials | 3 | 2024 | 493 | 0.500 |
Why?
| | Violence | 1 | 2019 | 266 | 0.490 |
Why?
| | Tyrosine 3-Monooxygenase | 9 | 2019 | 72 | 0.460 |
Why?
| | Heart | 8 | 2024 | 655 | 0.450 |
Why?
| | Chest Pain | 2 | 2025 | 91 | 0.400 |
Why?
| | Neurons | 6 | 2016 | 1590 | 0.390 |
Why?
| | Cytokine Receptor gp130 | 4 | 2016 | 12 | 0.390 |
Why?
| | Ganglia, Sympathetic | 2 | 2016 | 14 | 0.380 |
Why?
| | Heart Failure | 5 | 2024 | 2236 | 0.360 |
Why?
| | Hypertension | 4 | 2024 | 1295 | 0.350 |
Why?
| | Norepinephrine Plasma Membrane Transport Proteins | 3 | 2007 | 6 | 0.340 |
Why?
| | Judaism | 1 | 2010 | 3 | 0.340 |
Why?
| | Emigration and Immigration | 1 | 2010 | 46 | 0.320 |
Why?
| | Catecholamines | 3 | 2006 | 98 | 0.310 |
Why?
| | Receptors, Nerve Growth Factor | 3 | 2013 | 17 | 0.290 |
Why?
| | Neurotransmitter Agents | 2 | 2012 | 81 | 0.290 |
Why?
| | Cell Transdifferentiation | 2 | 2020 | 31 | 0.280 |
Why?
| | Heart Ventricles | 4 | 2017 | 788 | 0.280 |
Why?
| | Electroretinography | 1 | 2007 | 48 | 0.280 |
Why?
| | Xylazine | 1 | 2007 | 14 | 0.280 |
Why?
| | Isoflurane | 1 | 2007 | 31 | 0.270 |
Why?
| | Ethnopsychology | 1 | 2007 | 5 | 0.270 |
Why?
| | United Kingdom | 2 | 2025 | 318 | 0.270 |
Why?
| | Social Change | 1 | 2007 | 15 | 0.270 |
Why?
| | Behavioral Research | 1 | 2007 | 36 | 0.260 |
Why?
| | Anesthetics | 1 | 2007 | 81 | 0.260 |
Why?
| | Population Groups | 1 | 2007 | 62 | 0.260 |
Why?
| | Ketamine | 1 | 2007 | 94 | 0.260 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2016 | 135 | 0.250 |
Why?
| | Culture | 1 | 2007 | 128 | 0.250 |
Why?
| | Vulnerable Populations | 1 | 2007 | 163 | 0.240 |
Why?
| | Community Participation | 1 | 2007 | 131 | 0.240 |
Why?
| | Sympathectomy | 2 | 2017 | 6 | 0.240 |
Why?
| | Historiography | 1 | 2004 | 1 | 0.230 |
Why?
| | Myocardium | 3 | 2019 | 1002 | 0.230 |
Why?
| | Anesthesia | 1 | 2007 | 189 | 0.220 |
Why?
| | Angiotensin II | 1 | 2024 | 99 | 0.220 |
Why?
| | Health Services Research | 1 | 2007 | 404 | 0.220 |
Why?
| | Mice, Inbred C57BL | 9 | 2024 | 5757 | 0.210 |
Why?
| | Dobutamine | 2 | 2022 | 39 | 0.210 |
Why?
| | Postnatal Care | 1 | 2023 | 71 | 0.200 |
Why?
| | Aromatic-L-Amino-Acid Decarboxylases | 1 | 2002 | 2 | 0.200 |
Why?
| | Self-Management | 2 | 2023 | 176 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 69 | 0.200 |
Why?
| | Pterins | 1 | 2002 | 8 | 0.200 |
Why?
| | Arrhythmias, Cardiac | 3 | 2024 | 333 | 0.200 |
Why?
| | N-Acetylgalactosamine-4-Sulfatase | 1 | 2022 | 2 | 0.200 |
Why?
| | Acetylcholine | 4 | 2016 | 185 | 0.190 |
Why?
| | Exercise Test | 2 | 2023 | 625 | 0.190 |
Why?
| | Heart Rate | 3 | 2024 | 822 | 0.190 |
Why?
| | Fatigue | 1 | 2024 | 329 | 0.190 |
Why?
| | Sulfur | 1 | 2022 | 58 | 0.190 |
Why?
| | Calcium Signaling | 2 | 2024 | 249 | 0.190 |
Why?
| | Blood Pressure | 3 | 2023 | 1786 | 0.190 |
Why?
| | History, 20th Century | 3 | 2010 | 325 | 0.190 |
Why?
| | Myocardial Ischemia | 1 | 2023 | 263 | 0.180 |
Why?
| | Nicotine | 1 | 2024 | 334 | 0.180 |
Why?
| | Parasympathetic Nervous System | 3 | 2013 | 27 | 0.180 |
Why?
| | Male | 19 | 2025 | 67762 | 0.170 |
Why?
| | Female | 20 | 2025 | 73304 | 0.160 |
Why?
| | Cholinergic Neurons | 1 | 2020 | 17 | 0.160 |
Why?
| | Oxygen Consumption | 1 | 2023 | 696 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 170 | 0.160 |
Why?
| | Aged | 7 | 2025 | 23961 | 0.160 |
Why?
| | Ciliary Neurotrophic Factor | 3 | 2012 | 12 | 0.160 |
Why?
| | Antihypertensive Agents | 1 | 2023 | 494 | 0.160 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2019 | 9 | 0.160 |
Why?
| | Humans | 20 | 2025 | 137585 | 0.150 |
Why?
| | Mice | 15 | 2024 | 17787 | 0.150 |
Why?
| | Risk Assessment | 2 | 2025 | 3457 | 0.150 |
Why?
| | Animals | 21 | 2024 | 36940 | 0.150 |
Why?
| | Sympathetic Fibers, Postganglionic | 2 | 2011 | 4 | 0.140 |
Why?
| | Auditory Cortex | 1 | 2018 | 42 | 0.140 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2018 | 60 | 0.140 |
Why?
| | Sex Factors | 2 | 2024 | 2071 | 0.140 |
Why?
| | Torso | 1 | 2017 | 33 | 0.140 |
Why?
| | Photography | 1 | 2017 | 96 | 0.130 |
Why?
| | Heart Atria | 3 | 2013 | 137 | 0.130 |
Why?
| | Tinnitus | 1 | 2018 | 57 | 0.130 |
Why?
| | Prospective Studies | 3 | 2025 | 7604 | 0.130 |
Why?
| | Safety | 1 | 2018 | 338 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5131 | 0.120 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4295 | 0.120 |
Why?
| | Dopamine beta-Hydroxylase | 2 | 2016 | 14 | 0.110 |
Why?
| | Electrocardiography | 1 | 2017 | 629 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1502 | 0.110 |
Why?
| | Thioctic Acid | 1 | 2014 | 11 | 0.110 |
Why?
| | Rats | 7 | 2022 | 5647 | 0.110 |
Why?
| | Time Factors | 1 | 2025 | 6828 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 382 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 580 | 0.100 |
Why?
| | Mice, Knockout | 7 | 2020 | 3015 | 0.100 |
Why?
| | Aging | 2 | 2008 | 1864 | 0.100 |
Why?
| | Alzheimer Disease | 2 | 2014 | 560 | 0.100 |
Why?
| | Heart Injuries | 1 | 2013 | 37 | 0.100 |
Why?
| | Heart-Assist Devices | 1 | 2019 | 552 | 0.100 |
Why?
| | Physicians | 1 | 2022 | 910 | 0.100 |
Why?
| | Chondroitin Sulfate Proteoglycans | 2 | 2023 | 10 | 0.100 |
Why?
| | Middle Aged | 6 | 2025 | 33479 | 0.100 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 140 | 0.100 |
Why?
| | Cicatrix | 2 | 2023 | 64 | 0.090 |
Why?
| | Coronary Angiography | 2 | 2025 | 317 | 0.090 |
Why?
| | Heart Conduction System | 1 | 2012 | 99 | 0.090 |
Why?
| | Diet, High-Fat | 1 | 2013 | 247 | 0.090 |
Why?
| | Qualitative Research | 1 | 2019 | 1386 | 0.090 |
Why?
| | Gestalt Theory | 1 | 2010 | 2 | 0.080 |
Why?
| | Russia | 1 | 2010 | 11 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2012 | 810 | 0.080 |
Why?
| | Up-Regulation | 3 | 2011 | 843 | 0.080 |
Why?
| | Cytokines | 3 | 2009 | 2085 | 0.080 |
Why?
| | Rabbits | 2 | 2024 | 794 | 0.080 |
Why?
| | Artificial Intelligence | 2 | 2023 | 279 | 0.080 |
Why?
| | Faculty | 1 | 2010 | 147 | 0.080 |
Why?
| | Kidney | 1 | 2017 | 1468 | 0.080 |
Why?
| | Sodium | 1 | 2009 | 217 | 0.070 |
Why?
| | Receptor, Nerve Growth Factor | 1 | 2008 | 4 | 0.070 |
Why?
| | Choline O-Acetyltransferase | 2 | 2020 | 24 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2006 | 4193 | 0.070 |
Why?
| | Adaptation, Ocular | 1 | 2007 | 4 | 0.070 |
Why?
| | Dark Adaptation | 1 | 2007 | 13 | 0.070 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2007 | 17 | 0.070 |
Why?
| | Vision, Ocular | 1 | 2007 | 37 | 0.070 |
Why?
| | Anesthetics, Dissociative | 1 | 2007 | 30 | 0.070 |
Why?
| | Universities | 1 | 2010 | 433 | 0.070 |
Why?
| | Anesthetics, Inhalation | 1 | 2007 | 35 | 0.070 |
Why?
| | Oscillometry | 1 | 2007 | 42 | 0.070 |
Why?
| | Western World | 1 | 2007 | 7 | 0.070 |
Why?
| | Quality of Life | 1 | 2019 | 2892 | 0.070 |
Why?
| | History, 19th Century | 1 | 2007 | 60 | 0.070 |
Why?
| | Japan | 1 | 2007 | 115 | 0.070 |
Why?
| | Stroke Volume | 2 | 2023 | 612 | 0.070 |
Why?
| | Knowledge | 1 | 2007 | 55 | 0.070 |
Why?
| | Biomarkers | 3 | 2024 | 4149 | 0.060 |
Why?
| | Potassium Chloride | 1 | 2006 | 38 | 0.060 |
Why?
| | Social Support | 1 | 2010 | 618 | 0.060 |
Why?
| | United States | 3 | 2010 | 14841 | 0.060 |
Why?
| | Blotting, Western | 2 | 2012 | 1226 | 0.060 |
Why?
| | Retina | 1 | 2007 | 298 | 0.060 |
Why?
| | Ventricular Function, Left | 2 | 2024 | 534 | 0.060 |
Why?
| | Stellate Ganglion | 2 | 2019 | 5 | 0.060 |
Why?
| | Czechoslovakia | 1 | 2004 | 1 | 0.060 |
Why?
| | Developing Countries | 1 | 2007 | 307 | 0.060 |
Why?
| | Isolated Heart Preparation | 1 | 2024 | 6 | 0.060 |
Why?
| | Transdermal Patch | 1 | 2024 | 15 | 0.050 |
Why?
| | Administration, Cutaneous | 1 | 2024 | 129 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2007 | 351 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2007 | 2833 | 0.050 |
Why?
| | History, 21st Century | 1 | 2004 | 213 | 0.050 |
Why?
| | State Medicine | 1 | 2023 | 24 | 0.050 |
Why?
| | Reperfusion | 1 | 2023 | 40 | 0.050 |
Why?
| | Myostatin | 1 | 2023 | 25 | 0.050 |
Why?
| | Sweat Glands | 1 | 2002 | 4 | 0.050 |
Why?
| | Amyloidosis | 1 | 2003 | 42 | 0.050 |
Why?
| | Tissue Extracts | 1 | 2002 | 21 | 0.050 |
Why?
| | Pteridines | 1 | 2002 | 20 | 0.050 |
Why?
| | Nicotinic Agonists | 1 | 2024 | 129 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2006 | 840 | 0.050 |
Why?
| | Cell Polarity | 1 | 2003 | 141 | 0.050 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 322 | 0.050 |
Why?
| | Nerve Regeneration | 1 | 2022 | 59 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 552 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2016 | 2167 | 0.050 |
Why?
| | Proteoglycans | 1 | 2022 | 107 | 0.050 |
Why?
| | Foot | 1 | 2002 | 96 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 3 | 2013 | 2486 | 0.040 |
Why?
| | Pre-Eclampsia | 1 | 2023 | 190 | 0.040 |
Why?
| | Disease Management | 1 | 2025 | 628 | 0.040 |
Why?
| | Adiponectin | 1 | 2023 | 244 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2023 | 319 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2022 | 10811 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2003 | 220 | 0.040 |
Why?
| | Antigens | 1 | 2022 | 357 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2003 | 513 | 0.040 |
Why?
| | Adrenergic Neurons | 1 | 2020 | 6 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1783 | 0.040 |
Why?
| | Obesity | 1 | 2013 | 2992 | 0.040 |
Why?
| | Ischemia | 1 | 2023 | 409 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2003 | 433 | 0.040 |
Why?
| | Dopamine | 1 | 2002 | 303 | 0.040 |
Why?
| | Rats, Inbred WKY | 1 | 2019 | 36 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 340 | 0.040 |
Why?
| | Echocardiography | 1 | 2021 | 642 | 0.040 |
Why?
| | Tyramine | 2 | 2008 | 8 | 0.040 |
Why?
| | Synaptic Transmission | 2 | 2012 | 289 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3412 | 0.040 |
Why?
| | Skin | 1 | 2002 | 752 | 0.030 |
Why?
| | Genotype | 2 | 2016 | 1916 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1587 | 0.030 |
Why?
| | Electrodes | 1 | 2017 | 114 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2607 | 0.030 |
Why?
| | Observer Variation | 1 | 2017 | 343 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2031 | 0.030 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2828 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1477 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2017 | 455 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3566 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 423 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2016 | 284 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2014 | 21 | 0.030 |
Why?
| | Mental Status Schedule | 1 | 2014 | 33 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 3196 | 0.030 |
Why?
| | Adult | 3 | 2023 | 37929 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 752 | 0.030 |
Why?
| | Epinephrine | 1 | 2013 | 139 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5472 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6079 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2057 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2111 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2014 | 413 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 496 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2014 | 1993 | 0.020 |
Why?
| | Brain Stem | 1 | 2009 | 94 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5742 | 0.020 |
Why?
| | Transgenes | 1 | 2009 | 180 | 0.020 |
Why?
| | Growth Cones | 1 | 2008 | 7 | 0.020 |
Why?
| | Neurotrophin 3 | 1 | 2008 | 9 | 0.020 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2008 | 17 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1710 | 0.020 |
Why?
| | Nerve Growth Factor | 1 | 2008 | 30 | 0.020 |
Why?
| | Tachycardia | 1 | 2008 | 57 | 0.020 |
Why?
| | Angiotensinogen | 1 | 2007 | 4 | 0.020 |
Why?
| | Sympathomimetics | 1 | 2007 | 21 | 0.020 |
Why?
| | Ligation | 1 | 2007 | 92 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1759 | 0.020 |
Why?
| | Presynaptic Terminals | 1 | 2008 | 88 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2691 | 0.020 |
Why?
| | Adrenergic beta-Agonists | 1 | 2007 | 134 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2007 | 240 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 13209 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2007 | 341 | 0.020 |
Why?
| | Coronary Vessels | 1 | 2007 | 248 | 0.020 |
Why?
| | Leukemia Inhibitory Factor | 1 | 2003 | 6 | 0.010 |
Why?
| | GTP Cyclohydrolase | 1 | 2003 | 9 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2003 | 43 | 0.010 |
Why?
| | Lymphokines | 1 | 2003 | 131 | 0.010 |
Why?
| | Symporters | 1 | 2003 | 66 | 0.010 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2003 | 66 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7635 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 976 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1991 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 350 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2008 | 1100 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2003 | 886 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21513 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2003 | 778 | 0.010 |
Why?
| | Child | 1 | 2018 | 21935 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1242 | 0.010 |
Why?
| | Hippocampus | 1 | 2003 | 895 | 0.010 |
Why?
| | Inflammation | 1 | 2003 | 2837 | 0.010 |
Why?
|
|
Woodward's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|